JAMDA
Volume 7, Issue 5 , Pages 334-335 , June 2006

Why Health Care Providers Don’t Prescribe Warfarin to a Frail Nursing Home Resident With Atrial Fibrillation

References 

  1. Abel Latif AK , Peng X , Messinger-Rapport BJ . Predictors of anticoagulation prescription in nursing home residents with atrial fibrillation . J Am Med Dir Assoc . 2005;6:128–131
  2. Lau E , Bungard TJ , Tsuyuki RT . Stroke prophylaxis in institutionalized elderly patients with atrial fibrillation . J Am Geriatr Soc . 2004;52:428–433
  3. McCormick D , Gurwitz JH , Goldberg RJ , et al.   Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting . Arch Intern Med . 2001;161:2458–2463
  4. Dharmarajan TS , Varma S , Akkaladevi S , et al.   To anticoagulate or not to anticoagulate? A common dilemma for the providers: Physicians’ opinion poll based on a case study of an older long-term care facility resident with dementia and atrial fibrillation . J Am Med Dir Assoc . 2006;7:23–28
  5. Monette J , Gurwitz JH , Rochon PA , Avorn J . Physician attitudes concerning warfarin for stroke prevention in atrial fibrillation (Results of a survey of long-term care practitioners) . J Am Geriatr Soc . 1997;45:1060–1065
  6. Lip GYH , Hart RG , Conway DSG . Antithrombolic therapy for atrial fibrillation . BMJ . 2002;325:1022–1025
  7. Gage BF , Fihn SD , White RH . Warfarin therapy for an octogenarian who has atrial fibrillation . Ann Intern Med . 2001;134:465–474
  8. Boyd CM , Darer J , Bout C , et al.   Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases (Implications for Pay for Performance) . JAMA . 2005;294:716–724
  9. Taylor FC , Cohen H , Ebrahim S . Systemic review of long term anticoagulation or antiplatelet treatment in patients with non-rheumatic atrial fibrillation . BMJ . 2001;322:321–326
  10. Levine MN , Raskob G , Beyth RJ , et al.   Hemorrhagic complications of anticoagulant treatment (The seventh ACCP conference on antithromotic and thrombolytic therapy) . Chest . 2004;126:287S–310S
  11. Torn M , Bollen WLEM , van der Meer FJM , et al.   Risks of oral anticoagulant therapy with increasing age . Arch Intern Med . 2005;165:1527–1532
  12. Gage BF , Birman-Deych E , Kerzner R , et al.   Incidence of intracranial hemorrhage in patients with atrial fibrillation who are prone to fall . Am J Med . 2005;118:612–617
  13. Gage BF , Birman-Deych E , Radford MJ , et al.   Risk of osteoporotic fracture in elderly patients taking warfarin . Arch Intern Med . 2006;166:241–246
  14. Quilliam BJ , Lapane KL , Eaton CB , Mor V . Effect of antiplatelet and anticoagulant agents on risk of hospitalization for bleeding among a population of elderly nursing home stroke survivors . Stroke . 2001;32:2299–2304
  15. Man-Son-Hing M , Laupacis A . Anticoagulant-related bleeding in older persons with atrial fibrillation (Physicians fears often unfounded) . Arch Intern Med . 2003;163:1580–1586
  16. Bootman JL , Harrison Dl , Cox E . The health care cost of drug-related morbidity and mortality in nursing facilities . Arch Intern Med . 1997;157:2089–2096
  17. Desbiens NA . Deciding on anticoagulating the oldest old with atrial fibrillation (Insights from cost-effectiveness analysis) . J Am Geriatr Soc . 2002;50:863–869

PII: S1525-8610(06)00176-9

doi: 10.1016/j.jamda.2006.03.005

JAMDA
Volume 7, Issue 5 , Pages 334-335 , June 2006

Article Tools